From: Mutation-class dependent signatures outweigh disease-associated processes in cystic fibrosis cells
G542X | F508del | N1303K | G551D | I1234V |
---|---|---|---|---|
ALPK3 | ACTC | AHNK | CADH1 | CAN1 |
CLD6 | AFG32 | BGH3 | CAN1 | K1C19 |
CNDP2 | AHNK | CAN1 | COF1 | K2C5 |
EMAL3 | BGH3 | CCAR2 | INO1 | NALP2 |
GANAB | CADH3 | CLD6 | K1C14 | Â |
HNRL2 | CCAR2 | CPT1A | K2C80 | Â |
K1C14 | CLD6 | ERO1A | LRBA | Â |
K1C17 | CPT1A | K1C17 | OTUB1 | Â |
MYL6 | CTL2 | K1C19 | PLST | Â |
UBXN1 | EHD1 | K1C9 | TBL3 | Â |
ZCCHV | GSDME | K2C6A | ZCCHV | Â |
 | GSTO1 | ML12A |  |  |
 | K1C17 | MRE11 |  |  |
 | KI13A | NB5R1 |  |  |
 | KRT86 | NUMA1 |  |  |
 | ML12A | OTUB1 |  |  |
 | MRE11 | PAI2 |  |  |
 | NUMA1 | PDIA4 |  |  |
 | OTUB1 | PICAL |  |  |
 | PKP4 | PNCB |  |  |
 | PNPH | PNPH |  |  |
 | TACD2 | PURA2 |  |  |
 | TBB6 | RAB1B |  |  |
 | TENA | SFXN1 |  |  |
 | TOP2A | SQOR |  |  |
 | VDAC3 | SSBP |  |  |
 | YAP1 | TACD2 |  |  |
 |  | TBA4A |  |  |
 |  | TBB6 |  |  |
 |  | TELO2 |  |  |
 |  | TENA |  |  |
 |  | VATB2 |  |  |
 |  | VDAC3 |  |  |
 |  | YAP1 |  |  |
 |  | ZCCHV |  |  |